- Amarin (NASDAQ:AMRN) said it has appointed its executive vice president, Aaron Berg as CEO and president.
- The appointment comes after the resignation of Patrick Holt as CEO and president.
- Berg had joined the company in November 2012 and has more than 30 years of biopharmaceutical industry experience.